Heitmeier (SB 618) Act No. 397
Prior law provided for Carisoprodol as a Schedule IV controlled dangerous substance.
New law amends prior law to move Carisoprodol from a Schedule IV to a Schedule II
controlled dangerous substance.
New law provides that wholesale drug distributors licensed by the La. Board of Pharmacy
and registered with the U.S. Drug Enforcement Administration is exempt from the storage,
reporting, recordkeeping, and physical security requirements for any material, mixture,
compound, or preparation which contains any quantity of Carisoprodol.
Effective August 1, 2014.
(Amends R.S. 40:964(Schedule II)(D); repeals R.S. 40:964(Schedule IV)(B)(4.1))